Complement regulatory proteins and selective vulnerability of neurons to lysis on exposure to acetylcholinesterase antibody

Journal of Neuroimmunology

Volumn 115, Issue 1-2, 2001, Pages 53-63

  Tang, H ^a   Brimijoin, S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ACETYLCHOLINESTERASE ANTIBODY; ANTIBODY; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; PROTEIN CD59; PROTEIN CRRY; REAGENT; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CHOLINERGIC NERVE; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEX FORMATION; CONTROLLED STUDY; DIAPHRAGM MUSCLE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFERIOR MESENTERIC GANGLION; NERVE CELL; NERVE ENDING; NERVOUS SYSTEM; NONHUMAN; PREGANGLIONIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUPERIOR CERVICAL GANGLION; TARGET CELL;

ACETYLCHOLINESTERASE; ADRENAL GLANDS; ANIMALS; ANTIBODIES; ANTIGENS, CD59; ANTIGENS, SURFACE; COMPLEMENT SYSTEM PROTEINS; DIAPHRAGM; GANGLIA, PARASYMPATHETIC; GANGLIA, SYMPATHETIC; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; ORGAN SPECIFICITY; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; SPINAL CORD; SUPERIOR CERVICAL GANGLION; SYMPATHECTOMY, CHEMICAL;

EID: 0035795011     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00249-1     Document Type: Article

References (42)

1. Unique expression of HRF20 (CD59) in human nervous tissue
2. Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies
3. Death of intermediolateral spinal cord neurons follows selective, complement-mediated destruction of preganglionic sympathetic terminals by acetylcholinesterase antibodies
4. The pathogenesis of demyelinating disease: Insights from cell biology
5. CD59, an LY6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells
6. Express of the murine complement regulatory protein Crry
7. A rapid radiochemical method for the determination of choline acetyltransferase
8. Tissue distribution of complement regulatory membrane proteins in rats
9. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles
10. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55)
11. The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system
12. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria
13. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor
14. Guanethidine-induced destruction of sympathetic neurons
15. Mouse complement regulatory protein Crry/p65 utilizes the specific mechanisms of both human decay accelerating factor (DAF) and membrane cofactor protein (MCP)
16. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies
17. Mouse Crry/p65: Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF
18. Immune system response in Alzheimer's disease
19. Activation of the classical complement pathway in brain tissue of Alzheimer patients
20. Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain
21. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46)
22. Differential disruption of neurotransmission by acetylcholinesterase antibodies in pre- and paravertebral sympathetic ganglia examined with intracellular microelectrodes
23. Enhanced expression of complement regulatory proteins on thyroid epithelial cells of Graves' disease
24. Structure and function of decay accelerating factor CD55
25. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism
26. Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement
27. Monoclonal antibodies to rat brain acetylcholinesterase: Comparative affinity for soluble and membrane-associated enzyme and for enzyme from different vertebrate species
28. Complement activation by β-amyloid in Alzheimer disease
29. Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer's disease
30. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9
31. Molecular cloning of the rat complement regulatory protein, 5I2 antigen
32. Characterization of homologous restriction factor (HRF20) in human skin and leucocytes
33. The expression of complement regulatory proteins by adult human oligodendrocytes
34. Acute promyelocytic leukemia with CD59 deficiency
35. Regulatory control of complement on blood platelets
36. Differential expression of individual complement regulators in the brain and choroid plexus
37. Spinal origin of sympathetic preganglionic neurons in the rat
38. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells
39. Complement-mediated lesion of sympathetic ganglia in vitro with acetylcholinesterase antibodies
40. Anti-thyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells
41. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria
42. Expression and regulation of decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 in the human astroglioma cell line, D54-MG, and primary rat astrocytes